A 34-year-old woman with major depressive disorder and irritable bowel syndrome (IBS) presents for follow-up. Despite adherence to her SSRI and dietary changes for IBS, she reports persistent fatigue, bloating, and poor concentration. She asks whether a probiotic might help.

What are probiotics, and why should psychiatrists care?
Probiotics are live microorganisms that, when taken in adequate amounts, confer a health benefit to the host. Patients often seek them out as natural alternatives to medications, especially for gut and mood-related complaints.

One in four US adults now take probiotics, and many are bringing questions to their psychiatric clinicians about the gut-brain axis. This bidirectional communication links gut microbes to mood, cognition, and stress reactivity. Certain probiotic strains—sometimes called psychobiotics—may influence neurotransmitter activity (like serotonin and GABA), modulate the HPA axis, reduce inflammation, and strengthen the intestinal barrier. While these mechanisms aren’t fully established, they offer a rationale for considering probiotics in clinical psychiatry.

Depression
Among psychiatric conditions, depression has the strongest data supporting probiotic use. Meta-analyses show small to moderate symptom improvements, especially when probiotics are used alongside antidepressants rather than as monotherapy (Asad A et al, Nutr Rev 2025;83(7):e1504–e1520). The benefits are greater in clinical depression than in people with mild, stress-related depressive symptoms. Probiotics also have a few trials in treatment-resistant depression.

In one of the better-designed trials, adjunctive probiotics led to greater improvements in depressive symptoms compared with placebo, with modest benefits in anxiety (Nikolova V et al, JAMA Psychiatry 2023;80:842–847).

Clinical takeaway: Consider probiotics as a low-risk adjunct for patients with depression and partial antidepressant response, especially if they have GI symptoms or metabolic concerns.

Anxiety
The evidence for anxiety has been mixed, but a clearer picture is emerging: Probiotics appear to help in clinical anxiety disorders but not in healthy subjects or in anxiety secondary to medical conditions. Broad meta-analyses that pool these populations together tend to show weak, inconsistent effects (Liu B et al, Depress Anxiety 2018;35(10):935–945).

When meta-analyses restrict their focus to clinically diagnosed anxiety disorders, however, the picture improves. A 2025 meta-analysis of RCTs in psychiatric populations found a moderate reduction in anxiety symptoms with probiotics (SMD: –0.59; Asad et al, 2025). The one available RCT in DSM-diagnosed generalized anxiety disorder (GAD) found adjunctive probiotics plus sertraline superior to sertraline alone on the Hamilton Anxiety Rating Scale (Eskandarzadeh S et al, Nutr Neurosci 2021;24(2):102–108). That said, the overall evidence base for anxiety remains thin, and studies in healthy subjects and medical populations (eg, IBS) generally show no benefit, suggesting that any anxiolytic effect may depend on having a diagnosable anxiety disorder to begin with.

Clinical takeaway: Probiotics may offer modest anxiolytic benefit in patients with a DSM anxiety disorder, particularly as an adjunct to an SSRI. The data are weak and primarily from a single GAD trial, so don’t recommend probiotics for anxiety alone. However, if a patient with GAD or another anxiety disorder also has depression or metabolic concerns, the rationale for probiotic use is stronger.

Cognition
The evidence for probiotics is stronger for older adults, mild cognitive impairment (MCI), and Alzheimer’s dementia (Handajani YS et al, J Alzheimers Dis 2026;110(2):545–558). Meta-analyses show modest improvements in global cognition after 12 weeks of probiotic treatment, especially in memory domains (Peng TR et al, Gen Hosp Psychiatry 2025;97:284–293; Ma M et al, PLoS One 2025;20(5):e0321567). They are less effective in advanced dementia.

The proposed mechanisms include reduced inflammation (eg, lower hs-CRP), altered gut microbiota, and changes in indole metabolites.

Clinical takeaway: Consider probiotics in early cognitive impairment, particularly when systemic inflammation or metabolic dysfunction is present.

Metabolic health
Probiotics have consistent benefits in metabolic syndrome and type 2 diabetes, where they improve weight, waist circumference, lipids, glucose, insulin sensitivity, and inflammatory markers (Liu X et al, Nutr Metab Cardiovasc Dis 2025;35(9):104100). With the high rates of metabolic problems in psychiatric disorders, these findings are relevant to many patients. Antibiotics cause metabolic problems in part by disrupting the microbiome, and probiotics reduce the metabolic risks of antipsychotics (Huang J et al, Schizophr Bull 2022;48(4):850–859).

Clinical takeaway: Probiotics are more justifiable when patients have metabolic problems, particularly in patients with psychotropic-induced weight gain or metabolic syndrome.

When should psychiatrists recommend probiotics?
There is no formal test to identify candidates, but appropriate patients often fall into one of these groups:

• Depression with partial response to antidepressants
• Mood symptoms plus IBS or prominent GI complaints
• Metabolic syndrome or antipsychotic-associated weight gain
• Early MCI or Alzheimer’s disease

Use symptom scales like the Patient Health Questionnaire or the Montreal Cognitive Assessment to track outcomes. If metabolic health is a concern, consider baseline labs (A1c, glucose, lipids).

Product selection
The following are the top bacterial strains to look for in probiotic products:

• Lactobacillus family (acidophilus, paracasei, casei, plantarum, salivarius; to a lesser extent helveticus, lactis, delbrueckii, rhamnosus)
• Bifidobacterium families (bifidum, lactis, breve, longum; to a lesser extent infantis, subtilis)
• Streptococcus thermophilus

Stick with products that are verified by independent labs like ConsumerLab, USP, or NSF. Low-priced options that check these boxes are TruNature Advanced Digestive Probiotic and Member’s Mark 10 Strain Probiotic.

Prebiotics are the fibrous nutrients that probiotics feed on. Patients can get these by adding more fiber, nuts, vegetables, and fruits to their diet, or by taking a prebiotic. Synbiotics contain both prebiotics and probiotics and may work better than probiotics; the products recommended in the list above are synbiotics.

Avoid prescription probiotics like VSL#3, Visbiome, and Restora. These are formulated for infectious diseases and have counts of colony-forming units (CFUs) much higher than those used in psychiatry. (Dosages for our patients should aim for 2–10 billion CFUs.)

Duration
Most studies tested daily probiotics for one to three months. Long-term use appears safe, but we have limited data on how long to continue use. Some clinicians rotate products or suggest breaks, though evidence supporting these approaches is sparse.

Safety and side effects
Probiotics are generally well tolerated. Common side effects include mild bloating, gas, or loose stools—often transient. Rarely, infections have occurred in severely immunocompromised patients or those with central lines or structural heart disease. Bacterial overgrowth is sometimes mentioned as a risk, but studies find probiotics actually reduce this problem. They do not have drug interactions.

When probiotics aren’t enough
Set expectations clearly with patients. Probiotics are not replacements for psychiatric medications, and improvements—if any—while taking them tend to be modest and gradual.

Rather than presenting them as stand-alone treatments, frame probiotics as adjunctive. They should be used as a complement to foundational strategies: a healthy diet with prebiotics and fiber, exercise, sleep, and evidence-based psychiatric treatments.

CARLAT VERDICT
Probiotics won’t cure depression, anxiety, or cognitive decline, but they may offer modest benefits in depression, metabolic syndrome, and early cognitive impairment. When patients ask, you can confidently guide them toward safe products and realistic expectations. Used thoughtfully, probiotics are a low-risk adjunct—not a substitute—for psychiatric care.